Scientific production is a key indicator of a country's development [1, 2]. Cancer research is among the most active fields of biomedical research in the most similar countries. However, little empirical quantitative evidence is available to guide decisions on the orientation of specific research fields or the allocation of research resources [3]. Indeed, breast cancer research, along with care missions, teaching, and prevention, is the most appropriate scientific expression to improve prevention, screening, care, and other services for patients [4]. In general, research on breast cancer faces complex constraints, which require appropriate means and structures, with combined efforts of several disciplines and dynamic links between several research teams: hospitals, universities, and others.

Breast cancer research also aims to produce knowledge to better understand female cancer in its specificity and diversity in the national context, notably its risk factors, genetics, modes of care, and social repercussions [4, 5]. Breast cancer represents the first female cancer in the world [6-8], with an estimated 1.67 million new cases diagnosed in 2012 and 522,000 deaths per year [9]. In Morocco, its incidence is constantly increasing, making it currently the most frequent cancer in women. It is responsible for 36.4 new cases per 100,000 inhabitants per year according to the cancer registry of the greater Casablanca region and 43.4 new cases per 100,000 inhabitants according to the cancer registry of Rabat [10, 11]. It is also the most common cancer in women [12]. Each year, 2.3 million new cases are diagnosed, and more than 670,000 women die from the disease [13].

Compared to other countries [14, 15], Morocco's scientific production on oncology declined significantly between 1979 and 2009 [16, 17]. Notably, Morocco lacks a national journal that specializes in this topic. Furthermore, the number of scientific publications on breast cancer remains significantly lower than that of other Arab countries; research productivity in Egypt is higher, with a total of 582 publications (35.10%) [1].

To our knowledge, no study has evaluated scientific productivity in the field of breast cancer in women in Morocco. We aimed to perform a bibliometric analysis of articles on breast cancer during the period 2010-2022 in order to quantify research activity in Morocco through bibliometric indicators of measurement.

We conducted a bibliometric analysis including scientific publications (editorials, case reports, case series, original articles, systematic reviews, and meta-analyses) dealing with breast cancer in women published on PubMed during the period 2010-2022 with at least one author affiliated to Moroccan institution. We excluded articles that dealt with male breast cancer, as well as retracted and unfound articles.

We launched a search using the PubMed search engine with the keywords: breast neoplasm, its inclinations, and Morocco, as well as the cities with faculties of medicine and pharmacy (Marrakech, Casablanca, Rabat, Fez, Oujda, Agadir, Tangier). We selected the scientific publications between 2010 and 2022; two authors evaluated the titles of the articles, abstracts, and full texts, and then we selected the articles according to the inclusion criteria already mentioned.

We collected data from articles indexed on PubMed about breast cancer in women between 2010 and 2022, using a data sheet that was compiled throughout 2023. This data sheet contained bibliometric indicators related firstly to the article (title of the article, DOI, PMID, year of publication, year of the study, and type of publication). Secondly, the data sheet focused on the author, including the first author’s country of affiliation, the total number of authors, the order of Moroccan affiliation, the number of Moroccan authors, the institution of the first Moroccan author, the professional grade of the first Moroccan author, international and national collaborations, and H-index. Thirdly, the data sheet included bibliometric indicators that are specific to the study, such as the study’s access, type theme, study population, sample size, study architecture, language, number of citations, and funding resources. Finally, bibliometric indicators related to the publishing journal were included (Country and language of publication, indexing, scientific journal rankings—Scimago, research field, payment or free access to the scientific journal, acceptance rate, and open access). This study was conducted under the PRISMA 2020 guidelines (Supplementary file).

We analyzed the data using the Statistical Package for the Social Sciences (SPSS, version 21). We used descriptive statistics (percentages and frequencies) to describe the state of breast cancer research at the Moroccan level, and performed bivariate analysis using the chi-square test to identify the associated factors to international collaboration. The confidence interval was set at 95%, and a p-value of <0.05 was considered significant (Appendix 1).

In total, we found 506 scientific publications that met the inclusion criteria. A total of 79 of them were out of time, or none of the authors are affiliated with a Moroccan institution. Next, we eliminated an additional 96 scientific publications due to their retraction, inaccessibility, association with male breast cancer, or lack of a primary focus on breast cancer. Only 256 scientific publications made the final cut (Fig. 1).

In this study, we evaluated research activity on breast cancer in Morocco. We used the PubMed database to explore research activities [18, 19]. To our knowledge, this is the first updated bibliometric study aimed at describing the state of breast cancer research activity in the Moroccan context. We identified only one similar national bibliometric study covering the period 1979–2009 [16]. However, while researchers have previously examined the productivity of global breast cancer research, they did not specifically focus on the Arab region [20].

Our study reveals that Morocco published 256 studies on breast cancer between 2010 and 2022. This finding provides important information for future analyses and for health policymakers [21, 22]. Despite the valuable contributions of Arabs to medicine throughout history, other studies have shown that most Arab countries neglected breast cancer research during the 1980s [23]. Reports indicate that medical research activity in the Arab world still lags behind that of non-Arab countries in the region, such as Turkey and Iran [24, 25].

In fact, many Arab countries with strong economies, such as Bahrain, consider breast cancer research activity to be low, with only 7% of studies conducted on the disease. However, in Egypt and Saudi Arabia, this activity has experienced strong growth. The weakness of breast cancer research in some Arab countries is a multifaceted problem [25-27].

A study published in 2015 listed publications on “breast cancer” in the ISI Web of Science database to assess the quantity and quality of research from Arab countries. This study analyzed only original research and review articles. Research productivity was evaluated by examining the number of publications and their evolution over time, journal names, citation analysis, the top 10 contributing institutions, and each country’s overall contribution to breast cancer research. The study identified a total of 1,658 original research and review articles from Arab countries [1].

Our findings revealed two distinct phases in Moroccan breast cancer scientific production. Between 2010 and 2015, annual research output was relatively low, totaling 78 publications over six years. From 2016 to 2022, annual output increased significantly, with 178 publications over five years. Overall, we recorded a total of 256 publications over the twelve-year period.

This significant increase in Moroccan breast cancer research is partly attributed to the launch of the 1st National Plan for Cancer Prevention and Control (PNPCC, 2010–2019) [28], which was implemented through an effective partnership between the Lalla Salma Association for Cancer Control and the Ministry of Health. As part of the national plan, measure 30 aimed to strengthen research on cancer prevention, including: (a) basic research into prevention; (b) studies on the incidence, mortality, and prevalence of specific cancer types; (c) research to identify and quantify risk factors; (d) operational research on the cost-effectiveness of preventive actions; (e) studies in behavioral sciences and socio-anthropology; and (f) research on familial cancers [28].

Additionally, the establishment of regional oncology centers within university hospitals sought to implement “measure 47,” which focuses on providing specialized care, training, and advanced research activities [28]. The expansion of public university research institutions in Morocco has particularly contributed to the increase in scientific output. These institutions, including university hospitals (89 studies), faculties of science (65 studies), faculties of medicine and pharmacy (40 studies), and national oncology institutes (33 studies), have collectively published 229 studies.

Moreover, private academic and non-academic institutions are increasingly contributing to breast cancer research in Morocco. Comparatively, Egypt shows the highest research productivity among Arab countries, with a total of 582 publications (35.10%), primarily from public academic institutions, especially Cairo University, which accounts for 149 publications [1]. In contrast, the lower scientific output in other Arab countries is largely due to inadequate research infrastructure in many cancer control institutions [25].

The analysis of the main bibliometric indicators related to scientific production on breast cancer in Morocco revealed that international collaboration plays a crucial role in breast cancer research in Morocco between 2010 and 2022. This includes factors, such as funding, access to publications, study architecture, language of publication, first author's grade, number of citations, and H-index, all of which are statistically significant. Consequently, the main factors associated with international collaboration were the presence of funding (p<0.001), closed access publication (p=0.016), multicentric design (p <0.001), articles written in English, and the first author's high H-index (p<0.001). This result suggests that Moroccan researchers with a high H-index play a central role in establishing international collaborations. Their academic visibility and scientific recognition—often earned through previous high-impact publications—facilitate the development of cooperative networks beyond national borders. This observation aligns with the findings of Wagner and Leydesdorff [29] and Gazni et al [30], who emphasize that highly cited researchers act as strategic nodes in global research networks, particularly in oncology. Therefore, promoting career development and research training could indirectly support the integration of Moroccan research into larger-scale international projects.

Similarly, Sweileh et al. [1] have noted that Arab researchers collaborate with non-Arab researchers, especially those from the United States (305; 18.40%), in breast cancer research and production. Other studies show that the United States, Germany, and China are the most active and specialized countries in terms of publications related to breast cancer [31]. Moroccan authors target the bibliometric indicators of 19 “Open Access” journals, and 73.7% are indexed in databases, such as Web of Science, Scopus, and PubMed. Of these indexed journals, 50% have an SJR (Scientific Journal Rankings) of Q2. However, Sweileh et al. [1] reported that the Web of Science does not index the majority of the 10 scientific journals in which Arab authors published their breast cancer studies.

Our research revealed that only 16% of the studies received funding. Of these, 46.3% benefited from national funding, primarily from the 'Lalla Salma Foundation for Cancer Prevention and Treatment,' the only Moroccan association recognized as a public utility. Meanwhile, 53.7% of the funding came from international collaborations, of which 81.8% originated from high-income countries. This highlights that international collaboration is one of the key mechanisms to improve research funding on breast cancer in our context.

Similarly, the government funded part of the breast cancer research activity in Egypt and Saudi Arabia [25]. In 2020, a study at the National University of Seoul in the Republic of Korea showed that diversifying national funding sources, especially government ones, fosters research projects on intricate subjects, even at the molecular level [32]. Indeed, the promotion of diverse national funding sources impacts the scope of research projects [33].

Morocco's institutional framework significantly influences the availability of research funding for breast cancer, with government policies and universities playing a central role. Since 2010, the Moroccan government has implemented a National Plan for Cancer Prevention and Control, which provides financial support for basic cancer care services, including breast cancer. This plan highlights the government's commitment to combating cancer through structured national strategies [34]. Moroccan universities also play a crucial role within this framework, as their contribution to socio-economic development is increasingly recognized through research activities, including cancer research [35, 36].

The modesty of government and non-government funding, as well as poor cooperation between industry and academia, are hindrances to productivity in scientific research [32]. Arab governments should consider these factors if they wish to improve the status of their scientific research [18, 37]. This study has several strengths, including its comprehensive nature; to our knowledge, it is the first study to evaluate scientific production in breast cancer in Morocco from 2010 to 2022. However, it presents some limitations, in particular the lack of similar studies on scientific production in breast cancer from 2010 to 2022 in Morocco, making it difficult to compare our results with the literature. We also acknowledge that our research was limited to the PubMed database, which may have led us to overlook other publications indexed in different databases.

This bibliometric analysis demonstrated that there are limited research contributions on breast cancer in women in Morocco. Case reports and case series on breast cancer in women largely dominate this topic, providing a preliminary description of scientific productivity. Scientific research publications on breast cancer in women in Morocco are insufficient. This paper constitutes the first study conducted at the national and regional level over the previous twelve years, “2010 to 2022”. Indeed, breast cancer research in Morocco holds promising potential but remains hindered by a lack of funding, insufficient training, and limited collaboration. To enhance the quality and visibility of scientific output, it is essential to strengthen researchers' capacities, promote evidence-based studies, and encourage both national and international partnerships through structured projects and scientific exchange platforms [38, 39]. This will undoubtedly enhance future research outcomes in this field. A re-evaluation of the literature published on breast cancer research in women in Morocco is planned for the coming years [40].